6 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #Crizotinib #ALK ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
classification of NSCLC ... mutations and ALK ... #Diagnosis #Honc ... #Algorithm #NSCLC ... #PDL1 #NEJM
Perirenal Extramedullary Hematopoiesis - Magnetic resonance imaging of the abdomen, performed without the administration of contrast
hemosiderin deposition, all ... hematopoiesis #cilnical #Radiology ... #Pathology #Honc ... ExtramedullaryHematopoiesis #Microscopy ... #NEJM
Glucagonoma-Associated Rash - The rash involved the arms, genitals, and buttocks and had progressed to the
D) #Clinical #HONC ... Derm #Pathology #Radiology ... Glucagonoma #Rash #Microscopy ... #CT #NEJM